The results indicated that inhibition of ERK phosphorylation by metformin is at least partly mediated the inhibition of P70S6K activation and increase of sensitivity to gemcitabine in pancreatic cancer cells by attenuating CD133+ cells. The gene discussed is RPS6KB1; the disease is familial pancreatic carcinoma.